Cargando…
Finding missed cases of familial hypercholesterolemia in health systems using machine learning
Familial hypercholesterolemia (FH) is an underdiagnosed dominant genetic condition affecting approximately 0.4% of the population and has up to a 20-fold increased risk of coronary artery disease if untreated. Simple screening strategies have false positive rates greater than 95%. As part of the FH...
Autores principales: | Banda, Juan M., Sarraju, Ashish, Abbasi, Fahim, Parizo, Justin, Pariani, Mitchel, Ison, Hannah, Briskin, Elinor, Wand, Hannah, Dubois, Sebastien, Jung, Kenneth, Myers, Seth A., Rader, Daniel J., Leader, Joseph B., Murray, Michael F., Myers, Kelly D., Wilemon, Katherine, Shah, Nigam H., Knowles, Joshua W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550268/ https://www.ncbi.nlm.nih.gov/pubmed/31304370 http://dx.doi.org/10.1038/s41746-019-0101-5 |
Ejemplares similares
-
Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia
por: Sarraju, Ashish, et al.
Publicado: (2019) -
COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
por: Myers, Kelly D., et al.
Publicado: (2021) -
Letter to the Editor in response to “Response to Kovanen PT, et al. Letter to the Editor” for original article COVID-19 increases risk of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
por: Myers, Kelly D., et al.
Publicado: (2021) -
Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes
por: Myers, Kelly D., et al.
Publicado: (2019) -
Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
por: Cuchel, Marina, et al.
Publicado: (2023)